[1]Lim J,KimJ,Cheon S.A deep neural network-based method for early detection of osteoarthritis using statistical data[J].Int J Environ Res Public Health,2019,16(7):1281-1292.
[2]Theo V,Amanuel AA,Cristiana A,et al.Global,regional,and national incidence,prevalence,and years lived with disability for 328 diseases and injuries for 195 countries.1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet,2017,390(10100):1211-1259.
[3]HiligsmannM,CooperC,ArdenN,et al.Health economics in the field of osteoarthritis:an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis(ESCEO)[J].Semin Arthritis Rheum,2013,43(3):303-313.
[4]Zhang Yuqing,Niu Jingbo.Editorial:Shifting gears in osteoarthritis research toward symptomatic osteoarthritis[J].Arthritis Rheumatol,2016,68(8):1797-1800.
[5]Yoshioka K,Katayama M,Nishiyama T,et al.Biocompatibility study of different hyaluronan products for intra-articular treatment of knee osteoarthritis[J].BMC Musculoskelet Disord,2019,20(1):424-433.
[6]Zu Y,MuY,Li Q,et al.Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis[J].J Orthop Surg Res,2019,14(1):307-319.
[7]Favero M,Belluzzi E,Trisolino G,et al.Inflammatory molecules produced by meniscus and synovium in early and end-stage osteoarthritis:a coculture study [J].J Cell Physiol,2019,234(7):11176-11187.
[8]Sacitharan PK.Ageing and osteoarthritis[J].SubcellBiochem,2019(91):123-159.
[9]王波,余楠生.膝骨关节炎阶梯治疗专家共识(2018年版)[J].中华关节外科杂志(电子版),2019,13(1):124-130
[10]Yip K,Oettinger J.Why are we still using opioids for osteoarthritis?[J].Int J ClinPract,2020,74(1):e13416.
[11]Mahendira L,Jones C,Papachristos A,et al.Comparative clinical and cost analysis between surgical and non-surgical intervention for knee osteoarthritis[J].Int Orthop,2020,44(1):77-83.
[12]Mobasheri A,Rayman MP,Gualillo O,et al.The role of metabolism in the pathogenesis of osteoarthritis[J].Nat Rev Rheumatol,2017,13(5):302-311.
[13]Zheng J,Li Q.Methylene blue regulates inflammatory response in osteoarthritis by noncoding long chain RNA CILinc02[J].J Cell Biochem,2019,120(3):3331-3338.
[14]Wang S,Song R,Wang Z,et al.S100A8/A9 in Inflammation[J].Front Immunol,2018(9):1298-1312.
[15]Ruan G,Xu J,Wang K,et al.Associations between serum S100A8/S100A9 and knee symptoms,joint structures and cartilage enzymes in patients with knee osteoarthritis [J].Osteoarthr Cartil,2019,27(1):99-105.
[16]Ruan G,Xu J,Wang K,et al.Associations between serum IL-8 and knee symptoms,joint structures,and cartilage or bone biomarkers in patients with knee osteoarthritis[J].Clin Rheumatol,2019,38(12):3609-3617.
[17]Cremers NAJ,van den Bosch MHJ,van Dalen S,et al.S100A8/A9 increases the mobilization of pro-inflammatory Ly6C monocytes to the synovium during experimental osteoarthritis[J].Arthritis Res Ther,2017,19(1):217-232.
[18]Yammani RR.S100 proteins in cartilage:role in arthritis[J].Biochim Biophys Acta,2012,1822(4):600-606.
[19]S GN,Kamal W,George J,et al.Radiological and biochemical effects(CTX-II,MMP-3,8,and 13) of low-level laser therapy(LLLT) in chronic osteoarthritis in Al-Kharj,Saudi Arabia[J].Lasers Med Sci,2017,32(2):297-303.
[20]Thomas G,Tacke R,Hedrick CC,et al.Nonclassical patrolling monocyte function in the vasculature[J].Arterioscler Thromb Vasc Biol,2015,35(6):1306-1316.
[21]van Lent PL,Blom AB,Schelbergen RF,et al.Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis[J].Arthritis Rheum,2012,64(5):1466-1476.
[22]Fassl SK,Austermann J,Papantonopoulou O,et al.Transcriptome assessment reveals a dominant role for TLR4 in the activation of human monocytes by the alarmin MRP8[J].J Immunol,2015,194(2):575-583.
[23]DuttaP,Nahrendorf M.Monocytes in myocardial infarction[J].Arterioscler Thromb Vasc Biol,2015,35(5):1066-1070.
[24]Fahy N,de Vries-van Melle ML,Lehmann J,et al.Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state[J].Osteoarthr Cartil,2014,22(8):1167-1175.
[25]Murray PJ,Allen JE,Biswas SK,et al.Macrophage activation and polarization:nomenclature and experimental guidelines[J].Immunity,2014,41(1):14-20.
[26]Woodell-May JE,Sommerfeld SD.Role of inflammation and the immune system in the progression of osteoarthritis[J].J Orthop Res,2020,38(2):253-257.
[27]van den Bosch MH,Blom AB,Schelbergen RF,et al.Alarmin S100A9 induces proinflammatory and catabolic effects predominantly in the M1 macrophages of human osteoarthritic synovium[J].J Rheumatol,2016,43(10):1874-1884.
[28]Manferdini C,PaolellaF,GabusiE,et al.Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2:in vitro evaluation[J].Osteoarthr Cartil,2017,25(7):1161-1171.
[29]Di CI,Ascone G,Cremers NAJ,et al.Fcγ receptor-mediated influx of S100A8/A9-producing neutrophils as inducer of bone erosion during antigen-induced arthritis[J].Arthritis Res Ther,2018,20(1):80.
[30]van den Bosch MHJ.Inflammation in osteoarthritis:is it time to dampen the alarm(in) in this debilitating disease?[J].Clin ExpImmunol,2019,195(2):153-166.
[31]Vogl T,Ludwig S,Goebeler M,et al.MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes[J].Blood,2004,104(13):4260-4268.
[32]Schenten V,Plancon S,Jung N,et al.Secretion of the phosphorylated form of S100A9 from neutrophils is essential for the proinflammatory functions of extracellular S100A8/A9[J].Front Immunol,2018,9(5):447.
[33]Martel-Pelletier J,Barr AJ,Cicuttini FM,et al.Osteoarthritis[J].Nat Rev Dis Primers,2016,4(2):279-93.
[34]Tateiwa D,Yoshikawa H.Cartilage and bone destruction in arthritis:Pathogenesis and treatment strategy:A literature review[J].Cells,2019,8(8):818-849.
[35]Löfvall H,Newbould H,Karsdal MA,et al.Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes [J].Arthritis Res Ther,2018,20(1):67.
[36]Grevers LC,de Vries TJ,Vogl T,et al.S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4:implications for bone destruction in murine antigeninduced arthritis[J].Arthritis Rheum,2011,63(5):1365-1375.
[37]Väänänen HK,ZhaoH,Mulari M,et al.The cell biology of osteoclast function [J].J Cell Sci,2000,27(8):1229-1241.
[38]Vogl T,Tenbrock K,Ludwig S,et al.Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4,promoting lethal,endotoxin-induced shock[J].Nat Med,2007,13(9):1042-1049.
[39]Di CI,Blom AB,Davar R,et al.The alarmin S100A9 hampers osteoclast differentiation from human circulating precursors by reducing the expression of RANK[J].FASEB J,2019,33(9):10104-10115.
[40]Humphrey MB,Nakamura MC.A comprehensive review of immunoreceptor regulation of osteoclasts[J]Clin Rev Allergy Immunol,2016,51(1):48-58.
[41]Bekker PJ,Holloway DL,Rasmussen AS,et al.A single-dose placebo-controlled study of AMG 162,a fully human monoclonal antibody to RANKL,in postmenopausal women[J].J Bone Miner Res,2005,20(12):2275-2282.